Get started
Author

Zubair Jafar

Observed names: Z. Jafar, ZUBAIR M JAFAR
OpenAlex ID: A5109643152
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
2019 · Kausik K Ray, Helen M Colhoun, et al. · The Lancet Diabetes & Endocrinology · 315
PDF
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
2021 · Gregory G. Schwartz, Gregory G. Schwartz, et al. · Journal of the American College of Cardiology · 148
PDF
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
2022 · Emil Hagström, P. Gabriel Steg, et al. · Circulation · 118
PDF
Clinical Impact of Standardized TAVR Technique and Care Pathway
2023 · Kendra J. Grubb, Hemal Gada, et al. · JACC: Cardiovascular Interventions · 93
Feasibility of Combined Percutaneous Transluminal Angioplasty and Minimally Invasive Direct Coronary Artery Bypass in Patients With Multivessel Coronary Artery Disease
1998 · Howard A. Cohen, Marco Zenati, et al. · Circulation · 81
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
2017 · Muthiah Vaduganathan, Robert A. Harrington, et al. · Journal of the American College of Cardiology · 58
PDF
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
2021 · Gregory G. Schwartz, Michael Szarek, et al. · Diabetes Care · 40
PDF
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
2025 · P. Gabriel Steg, Michael Szarek, et al. · Circulation · 26
PDF
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
2024 · Shaun G Goodman, Philippe Gabriel Steg, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 25
PDF
The Cusp Overlap Technique Reduces Pacemaker Implantation in TAVR: A Systematic Review and Meta-analysis
2025 · Mohammad Hazique, Zubair Jafar, et al. · The American Journal of Cardiology · 9
Global Results From the Optimize PRO Study: Standardized TAVR Technique and Care Pathway
2025 · Kendra J. Grubb, Hemal Gada, et al. · Journal of the Society for Cardiovascular Angiography & Interventions · 5
A Novel Bridging Strategy for Patients Undergoing Emergent Non-Cardiac Surgery with a Recent Coronary Stent
2018 · Cierra Bruck, Omar Jafar, et al. · Cardiology and Therapy · 4
PDF
Integrated coronary revascularization—minimally invasive coronary bypass combined with angioplasty: initial experience in 25 patients
1998 · H.A. Cohen, M. Zenati, et al. · Journal of the American College of Cardiology · 2
PDF
Correction to: A Novel Bridging Strategy for Patients Undergoing Emergent Non-Cardiac Surgery with a Recent Coronary Stent
2018 · Cierra Bruck, Omar Jafar, et al. · Cardiology and Therapy · 1
PDF
Nocturia and Left Ventricular End-Diastolic Pressure in Patients Undergoing Left Sided Cardiac Catheterization
2026 · Mohammad Hazique, Thomas F. Monaghan, et al. · Journal of Community Health
Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR
2026 · Danny Dvir, Hasan A. Jilaihawi, et al. · JACC: Cardiovascular Interventions
Anomalous Left Coronary Artery From Right Coronary Origin Wrapping Around Aortic Annulus and Potential Interaction With the Valve Insertion During Tavr: a Case Report
2023 · IBRAR ANJUM, SHERAZ ANJUM, et al. · CHEST Journal
Serial electrophysiologic studies do not predict success in patients with rapid ventricular tachycardia
1991 · Lee A. Biblo, Raul Mitrani, et al. · Journal of the American College of Cardiology
PDF
Works count: 19
Citation count: 924
H-index: 9
I10-index: 9
Year
Topic
Type